TARA
Protara Therapeutic Inc
NASDAQ · Biotechnology
$6.65
+0.15 (+2.31%)
Open$6.66
Previous Close$6.50
Day High$6.89
Day Low$6.60
52W High$23.05
52W Low$15.60
Volume—
Avg Volume497.7K
Market Cap343.34M
P/E Ratio23.12
EPS$0.75
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+252.5% upside
Current
$6.65
$6.65
Target
$23.44
$23.44
$15.10
$23.44 avg
$28.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 193.62M | 202.51M | 206.29M |
| Net Income | -27,587,371 | -28,749,471 | -33,771,699 |
| Profit Margin | -14.3% | -14.2% | -16.4% |
| EBITDA | -51,862,975 | -48,122,998 | -52,884,989 |
| Free Cash Flow | -39,587,712 | -47,283,878 | -36,549,207 |
| Rev Growth | +24.4% | +2.2% | +1.5% |
| Debt/Equity | 0.26 | 0.22 | 0.30 |
Dividend
Dividend Yield2.21%
Annual Dividend$0.38
Payout Ratio51.2%
Frequencyquarterly
Ex-DividendMar 21, 2026
Pay DateApr 7, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |